Literature DB >> 15972363

Exothermal characteristics and release of residual monomers from fiber-reinforced oligomer-modified acrylic bone cement.

Mervi A Puska1, Lippo V J Lassila, Allan J Aho, Antti Yli-Urpo, Pekka K Vallittu, Ilkka Kangasniemi.   

Abstract

The aim of this study is to determine the peak temperature of polymerization, the setting time and the release of residual monomers of a modified acrylic bone cement. Palacos R, a commercial bone cement, is used as the main component. The cement is modified by adding short glass fibers and resorbable oligomer fillers, and an additional cross-linking monomer. The test specimens are classified according to the composition of the bone cement matrix (i.e., oligomer-filler, glass-fiber reinforcement, and/or cross-linking monomer). The exothermal characteristics during autopolymerization are analyzed using a transducer connected with a computer. The quantities of residual monomers were analyzed from different test groups using high performance liquid chromatography (HPLC). The DeltaT value for the oligomer filler and the glass-fiber-containing acrylic bone cement is lower than that for the unmodified bone cement (2.1 +/- 0.8 vs. 23.5 +/- 4.2 degrees C). The addition of a cross-linking monomer, EGDMA, shortens the setting time of the autopolymerization of the unmodified bone cement (7.1 +/- 0.9 min vs. 3.3 +/- 0.3 min). The quantity of the residual monomers released is higher in the modified bone cement than that in the unmodified cement. The cement that contains glass fibers and oligomer fillers has a considerably lower exothermal peak, whereas the total quantity of residual monomers released is increased.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972363     DOI: 10.1177/0885328205048647

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  1 in total

1.  Osteoblast response to polymethyl methacrylate bioactive glass composite.

Authors:  M Hautamäki; V V Meretoja; R H Mattila; A J Aho; P K Vallittu
Journal:  J Mater Sci Mater Med       Date:  2010-02-17       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.